Quarterly report pursuant to Section 13 or 15(d)

Pro Forma Condensed Combined Balance Sheets (Parenthetical)

v3.21.1
Pro Forma Condensed Combined Balance Sheets (Parenthetical)
Mar. 31, 2021
$ / shares
shares
Preferred stock, no par value | $ / shares
Preferred stock, shares authorized 50,000,000
Common stock, no par value | $ / shares
Common stock, shares authorized 100,000,000
Common stock, shares issued 8,326,730
Common stock, shares outstanding 8,326,730
Series C Convertible Preferred Stock [Member]  
Preferred stock, shares authorized 1,990,000
Preferred stock, par value per share | $ / shares
Preferred stock, stated value | $ / shares $ 4.00
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
Series D Convertible Preferred Stock [Member]  
Preferred stock, shares authorized 211,353
Preferred stock, par value per share | $ / shares
Preferred stock, stated value | $ / shares $ 0.01
Preferred stock, shares issued 72,992
Preferred stock, shares outstanding 72,992
Series E Junior Participating Preferred Stock [Member]  
Preferred stock, shares authorized 100,000
Preferred stock, par value per share | $ / shares
Preferred stock, stated value | $ / shares $ 0.001
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
Pro Forma [Member]  
Preferred stock, no par value | $ / shares $ 50,000,000
Common stock, no par value | $ / shares
Common stock, shares authorized 90,000,000
Common stock, shares outstanding 40,043,504
Pro Forma [Member] | Series C Convertible Preferred Stock [Member]  
Preferred stock, shares authorized 1,990,000
Preferred stock, par value per share | $ / shares
Preferred stock, stated value | $ / shares $ 4.00
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
Pro Forma [Member] | Series D Convertible Preferred Stock [Member]  
Preferred stock, shares authorized 211,353
Preferred stock, par value per share | $ / shares $ 0
Preferred stock, stated value | $ / shares $ 0.01
Preferred stock, shares issued 72,992
Preferred stock, shares outstanding 72,992
Pro Forma [Member] | Series E Junior Participating Preferred Stock [Member]  
Preferred stock, shares authorized 100,000
Preferred stock, par value per share | $ / shares $ 0
Preferred stock, stated value | $ / shares $ 0.001
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
Pro Forma [Member] | Common Sock No Par Value [Member]  
Common stock, no par value | $ / shares
Common stock, shares authorized 100,000,000
Common stock, shares issued 8,326,730
Common stock, shares outstanding 8,326,730
Pro Forma [Member] | Legal Acquirer Company [Member]  
Preferred stock, no par value | $ / shares $ 50,000,000
Common stock, no par value | $ / shares
Common stock, shares authorized 90,000,000
Common stock, shares outstanding 40,043,504
Pro Forma [Member] | Legal Acquirer Company [Member] | Series C Convertible Preferred Stock [Member]  
Preferred stock, shares authorized 1,990,000
Preferred stock, par value per share | $ / shares
Preferred stock, stated value | $ / shares $ 4.00
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
Pro Forma [Member] | Legal Acquirer Company [Member] | Series D Convertible Preferred Stock [Member]  
Preferred stock, shares authorized 211,353
Preferred stock, par value per share | $ / shares $ 0
Preferred stock, stated value | $ / shares $ 0.01
Preferred stock, shares issued 72,992
Preferred stock, shares outstanding 72,992
Pro Forma [Member] | Legal Acquirer Company [Member] | Series E Junior Participating Preferred Stock [Member]  
Preferred stock, shares authorized 100,000
Preferred stock, par value per share | $ / shares $ 0
Preferred stock, stated value | $ / shares $ 0.001
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
Pro Forma [Member] | Legal Acquirer Company [Member] | Common Sock No Par Value [Member]  
Common stock, no par value | $ / shares
Common stock, shares authorized 100,000,000
Common stock, shares issued 8,326,730
Common stock, shares outstanding 8,326,730
Pro Forma [Member] | Accounting Acquirer MyMD [Member]  
Preferred stock, no par value | $ / shares $ 50,000,000
Common stock, no par value | $ / shares
Common stock, shares authorized 90,000,000
Common stock, shares outstanding 40,043,504
Pro Forma [Member] | Accounting Acquirer Pre-Merger MYMD Florida [Member] | Series C Convertible Preferred Stock [Member]  
Preferred stock, shares authorized 1,990,000
Preferred stock, par value per share | $ / shares
Preferred stock, stated value | $ / shares $ 4.00
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
Pro Forma [Member] | Accounting Acquirer Pre-Merger MYMD Florida [Member] | Series D Convertible Preferred Stock [Member]  
Preferred stock, shares authorized 211,353
Preferred stock, par value per share | $ / shares $ 0
Preferred stock, stated value | $ / shares $ 0.01
Preferred stock, shares issued 72,992
Preferred stock, shares outstanding 72,992
Pro Forma [Member] | Accounting Acquirer Pre-Merger MYMD Florida [Member] | Series E Junior Participating Preferred Stock [Member]  
Preferred stock, shares authorized 100,000
Preferred stock, par value per share | $ / shares $ 0
Preferred stock, stated value | $ / shares $ 0.001
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
Pro Forma [Member] | Accounting Acquirer Pre-Merger MYMD Florida [Member] | Common Sock No Par Value [Member]  
Common stock, no par value | $ / shares
Common stock, shares authorized 100,000,000
Common stock, shares issued 8,326,730
Common stock, shares outstanding 8,326,730
Cystron Biotech Spin-Off Adjustments [Member]  
Preferred stock, no par value | $ / shares $ 50,000,000
Common stock, no par value | $ / shares
Common stock, shares authorized 90,000,000
Common stock, shares outstanding 40,043,504
Cystron Biotech Spin-Off Adjustments [Member] | Series C Convertible Preferred Stock [Member]  
Preferred stock, shares authorized 1,990,000
Preferred stock, par value per share | $ / shares
Preferred stock, stated value | $ / shares $ 4.00
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
Cystron Biotech Spin-Off Adjustments [Member] | Series D Convertible Preferred Stock [Member]  
Preferred stock, shares authorized 211,353
Preferred stock, par value per share | $ / shares $ 0
Preferred stock, stated value | $ / shares $ 0.01
Preferred stock, shares issued 72,992
Preferred stock, shares outstanding 72,992
Cystron Biotech Spin-Off Adjustments [Member] | Series E Junior Participating Preferred Stock [Member]  
Preferred stock, shares authorized 100,000
Preferred stock, par value per share | $ / shares $ 0
Preferred stock, stated value | $ / shares $ 0.001
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
Cystron Biotech Spin-Off Adjustments [Member] | Common Sock No Par Value [Member]  
Common stock, no par value | $ / shares
Common stock, shares authorized 100,000,000
Common stock, shares issued 8,326,730
Common stock, shares outstanding 8,326,730
Adjustments [Member]  
Preferred stock, no par value | $ / shares $ 50,000,000
Common stock, no par value | $ / shares
Common stock, shares authorized 90,000,000
Common stock, shares outstanding 40,043,504
Adjustments [Member] | Series C Convertible Preferred Stock [Member]  
Preferred stock, shares authorized 1,990,000
Preferred stock, par value per share | $ / shares
Preferred stock, stated value | $ / shares $ 4.00
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
Adjustments [Member] | Series D Convertible Preferred Stock [Member]  
Preferred stock, shares authorized 211,353
Preferred stock, par value per share | $ / shares $ 0
Preferred stock, stated value | $ / shares $ 0.01
Preferred stock, shares issued 72,992
Preferred stock, shares outstanding 72,992
Adjustments [Member] | Series E Junior Participating Preferred Stock [Member]  
Preferred stock, shares authorized 100,000
Preferred stock, par value per share | $ / shares $ 0
Preferred stock, stated value | $ / shares $ 0.001
Preferred stock, shares issued 0
Preferred stock, shares outstanding 0
Adjustments [Member] | Common Sock No Par Value [Member]  
Common stock, no par value | $ / shares
Common stock, shares authorized 100,000,000
Common stock, shares issued 8,326,730
Common stock, shares outstanding 8,326,730